Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Roberts' Agrylin available today in U.S.

April 14, 1997

FK-633 inhibits thrombosis and prevents restenosis in hamster model

April 14, 1997

Integrilin MAA withdrawn; companies await PURSUIT results

April 14, 1997

Genentech granted U.S. patents for factor VIII

April 11, 1997

Cohesion initiates clinical trials of CollaSeal

April 10, 1997

Xenova reports encouraging data on antithrombotic compound

April 10, 1997

T-686 inhibits PAI-1 and development of atherosclerotic lesions

April 8, 1997

Inogatran exerts selective inhibition of thrombin in vitro

April 8, 1997

Mitsubishi Chemical describes thrombin inhibitors

April 8, 1997

Haemacure to begin pivotal trials of Hemaseel HMN

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.